AbbVie Inc. 8K

AbbVie Inc. agreed to sell $10 billion of senior notes due 2028–2066 under an underwriting agreement with a syndicate led by Morgan Stanley, BofA Securities, J.P. Morgan and SG Americas, with closing on August 18, 2026.

AbbVie Inc. entered into an underwriting agreement dated August 4, 2026 with Morgan Stanley & Co. LLC, BofA Securities, Inc., J.P. Morgan Securities LLC, SG Americas Securities, LLC and a syndicate of other underwriters for the registered public offering and sale of multiple tranches of senior unsecured notes totaling $10,000,000,000, consisting of $500 million senior floating rate notes due 2028 and eight fixed‑rate senior note tranches with coupons ranging from 4.500% to 6.100% and maturities from 2028 to 2066, to be issued under its existing indenture with U.S. Bank Trust Company, National Association, with closing scheduled for August 18, 2026 and customary representations, covenants, conditions, indemnification and use of proceeds provisions.

Filing Facts

CIK

1551152

Ticker

ABBV

Form

8K

Source Type

fda

Accession

0001104659-26-091269

Alert Tier

7